Screening and Intervention Best Practices for Neonatal Opioid Withdrawal Syndrome (NOWS)

Illinois Primary Health Care Association 500 S 9th St, Springfield, IL, United States

This one-hour webinar is intended to increase the knowledge and skills needed to deliver evidence-based treatment for mothers affected by opioid use disorder and their infants who may be impacted by neonatal opioid withdrawal syndrome. Created for the medical and social work professionals, the webinar will address the following objectives: Define recommendations for assessing and

Free

Expanding SUD Services to Include Methadone for Opioid Use Disorder

Virtual

Mile Square Health Center and Family Guidance Center (FGC) has developed an integrated collaborative model that offers access to comprehensive behavioral health and MAR services in the primary care clinic. The program includes all three of the FDA approved medications, methadone, buprenorphine/naloxone, and naltrexone for those patients with OUD. Mile Square and FGC team members will

Free

Nicotine Addiction in Adolescents

Virtual

Dr. Maria Rahmandar is an attending physician in the Division of Adolescent and Young Adult Medicine at Lurie Children's Hospital, the Medical Director of the Substance Use & Prevention Program, and an Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine, with a secondary appointment in Psychiatry and Behavioral Sciences. She is board-certified

Free

Adolescent and Opioid Addiction

Virtual

Jennifer Kershaw Jensen, MSN, APRN-NP, CPNP is a Nurse Practitioner in The Potocsnak Family Division of Adolescent and Young Adult Medicine at Lurie Children's Hospital. Her clinical areas of expertise include substance use prevention and treatment as well as care for LGBTQ+ identified youth.   Learning Objectives:  Attendees will be able to identify risk factors

Free

IPHCA Half and Half X-Waiver Training: 4 Hour Live Interaction

Virtual

Course Objectives: Screen and identify patients with OUD and define evidence-based treatments. Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients. Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient. Explain the process of buprenorphine induction as well as stabilization and maintenance. Discuss

Free